IT1296495B1 - Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare - Google Patents

Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare

Info

Publication number
IT1296495B1
IT1296495B1 ITMI972603A IT1296495B1 IT 1296495 B1 IT1296495 B1 IT 1296495B1 IT MI972603 A ITMI972603 A IT MI972603A IT 1296495 B1 IT1296495 B1 IT 1296495B1
Authority
IT
Italy
Prior art keywords
bisphosphonates
preparation
intramuscular administration
pharmaceutical forms
pharmaceutical
Prior art date
Application number
Other languages
English (en)
Italian (it)
Inventor
Tiberio Bruzzese
Angelo Bonabello
Giovanni Mozzi
Original Assignee
Prodotti Antibiotici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Antibiotici Spa filed Critical Prodotti Antibiotici Spa
Priority to IT002603 priority Critical patent/IT1296495B1/it
Priority to ES9802412A priority patent/ES2152865B1/es
Priority to DE1998153483 priority patent/DE19853483A1/de
Priority to FR9814554A priority patent/FR2771638B1/fr
Priority to GB9825409A priority patent/GB2331459A/en
Priority to BE9800841A priority patent/BE1012137A3/fr
Publication of ITMI972603A1 publication Critical patent/ITMI972603A1/it
Application granted granted Critical
Publication of IT1296495B1 publication Critical patent/IT1296495B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT002603 1997-11-21 1997-11-21 Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare IT1296495B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT002603 IT1296495B1 (it) 1997-11-21 1997-11-21 Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
ES9802412A ES2152865B1 (es) 1997-11-21 1998-11-17 Utilizacion de bisfosfonatos en la preparacion de composiciones farmaceuticas para uso intramuscular.
DE1998153483 DE19853483A1 (de) 1997-11-21 1998-11-19 Verwendung von Biphosphonaten zur Herstellung von pharmazeutischen Darreichungsformen zur intramuskulären Verwendung
FR9814554A FR2771638B1 (fr) 1997-11-21 1998-11-19 Utilisation des bisphosphonates dans la preparation de formes pharmaceutiques destinees a un usage intramusculaire
GB9825409A GB2331459A (en) 1997-11-21 1998-11-19 Use of bisphosphonates in pharmaceutical preparations intended for intramuscular use
BE9800841A BE1012137A3 (fr) 1997-11-21 1998-11-20 Utilisation des bisphosphonates dans la preparation de formes pharmaceutiques destinees a un usage intramusculaire.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002603 IT1296495B1 (it) 1997-11-21 1997-11-21 Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare

Publications (2)

Publication Number Publication Date
ITMI972603A1 ITMI972603A1 (it) 1999-05-21
IT1296495B1 true IT1296495B1 (it) 1999-06-25

Family

ID=11378254

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002603 IT1296495B1 (it) 1997-11-21 1997-11-21 Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare

Country Status (6)

Country Link
BE (1) BE1012137A3 (fr)
DE (1) DE19853483A1 (fr)
ES (1) ES2152865B1 (fr)
FR (1) FR2771638B1 (fr)
GB (1) GB2331459A (fr)
IT (1) IT1296495B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1136069A1 (fr) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Compositions pharmaceutiques comprenant des clodronates ayant une haute tolérance locale de l'administration intramusculaire
SI1296689T1 (sl) * 2000-06-20 2006-08-31 Novartis Ag Nacin dajanja pacientu bisfosfonatov
US8052987B2 (en) 2000-06-20 2011-11-08 Novartis Pharmaceuticals Corporation Method of administering bisphosphonates
US6548042B2 (en) 2000-08-07 2003-04-15 Arstad Erik Bis-phosphonate compounds
ITTO20020406A1 (it) * 2002-05-13 2003-11-13 Chiesi Farma Spa Formulazioni di bisfosfonati ad uso iniettabile.
US20050203000A1 (en) * 2003-03-26 2005-09-15 Sutter Diane E. Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0051163A3 (fr) * 1980-11-03 1983-02-16 Dr. Franz Köhler Chemie KG Solution du chlorhydrate de 4-diméthylaminophénol à utilisation intramusculaire sans douleur et procédé de préparation
JPS5862652A (ja) * 1981-10-08 1983-04-14 Konishiroku Photo Ind Co Ltd 直接ポジカラ−画像の形成方法
JPH03190823A (ja) * 1989-12-21 1991-08-20 Snow Brand Milk Prod Co Ltd エリスロポエチン皮下又は筋肉投与剤
CA2035179C (fr) * 1990-01-31 2001-08-14 Gerald S. Brenner Composition pharmaceutique contenant des sels insolubles d'acides biphosphonique
EP0813414A4 (fr) * 1993-10-19 1999-07-21 Merck & Co Inc Combinaison de biphosphonates et de secretagogues de l'hormone de croissance
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices

Also Published As

Publication number Publication date
BE1012137A3 (fr) 2000-05-02
ITMI972603A1 (it) 1999-05-21
ES2152865B1 (es) 2001-08-16
GB2331459A8 (en) 1999-07-15
FR2771638B1 (fr) 2000-09-08
GB9825409D0 (en) 1999-01-13
ES2152865A1 (es) 2001-02-01
FR2771638A1 (fr) 1999-06-04
GB2331459A (en) 1999-05-26
DE19853483A1 (de) 1999-05-27

Similar Documents

Publication Publication Date Title
FI980822A7 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
DE69525148D1 (de) Pharmazeutische formulierung
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
DK0941075T3 (da) Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
FI963871L (fi) Farmaseuttinen formulointi tekijän VIII tai tekijän IX antamiseksi ihonalaisesti, lihaksensisäisesti tai ihonsisäisesti
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
IS5248A (is) Lyfjasamsetningar sem innihalda vorikónasól
ID29514A (id) 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT
DE59915033D1 (de) Pharmazeutische Zubereitung
PT868911E (pt) Formulacoes de rapamicina para administracao oral
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
ITMI972603A1 (it) Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
DE69827947D1 (de) Rapamycin-formulierungen zur oralen verabreichung
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
NO992999D0 (no) Farmas°ytisk blanding for oral administrering
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
IT1293819B1 (it) Procedimento per la preparazione di acarbosio
GB9817470D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
0001 Granted